Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
The study examined genetic alterations in more than 3,200 patients with lung cancer, focusing on key genes linked to ...
NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...
The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...
In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...
After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...
Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...
Health on MSN12d
What To Know about Stage 3 Lung CancerMedically reviewed by Marla Anderson, MD Lung cancer causes cancer cells to develop a tumor in the lungs' tissues. Lung ...
In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback